Precipio is a healthcare biotechnology company

focused on cancer diagnostics. Our mission is to address the pervasive problem

of cancer misdiagnoses by developing solutions in the form of diagnostic

products and services. Our products and services deliver higher accuracy,

improved laboratory workflow, and ultimately better patient outcomes, which

reduce healthcare expenses. Precipio develops innovative technologies in our

laboratory where we design, test, validate, and use these products clinically,

improving diagnostic outcomes. Precipio then commercializes these technologies

as proprietary products that serve the global laboratory community and further

scales Precipio’s reach to eradicate misdiagnosis.